About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Minneapolis | 7,818 Studies Near You

Clinical TrialsMinneapolis

Clinical Trials in Minneapolis

Discover 7,818 clinical trials near Minneapolis, Minnesota. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4561-4580 of 7,818 trials

WithdrawnComorbid Painful TMD Among Trigeminal NeuralgiaAn observational study following up with trigeminal neuralgia patients to understand their comorbid facial pain condition, specifically temporomandibular disorder.NCT05914558·Baltimore, Maryland and 1 other CompletedEffect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes ControlThe purpose of this study is to assess whether glycemic control (assessed with HbA1c measurement) in individuals with type 1 or type 2 diabetes can be improved with a…NCT01323348·Loma Linda, California and 33 others

Find Trials by Condition in Minneapolis

Breast Cancerin Minneapolis Lung Cancerin Minneapolis Prostate Cancerin Minneapolis Colorectal Cancerin Minneapolis Melanomain Minneapolis Leukemiain Minneapolis Lymphomain Minneapolis Pancreatic Cancerin Minneapolis Ovarian Cancerin Minneapolis Brain Cancerin Minneapolis

Data from ClinicalTrials.govTerms

CompletedBrain-Behavior Interactions in Tic SuppressionThe purpose of this study is to examine how the brain and environment interact to influence children's ability to suppress tics using a medical technology called Transcranial…NCT02205918·Minneapolis, Minnesota

CompletedDonors After Circulatory Death Heart TrialTo evaluate the effectiveness of the OCS Heart System to resuscitate, preserve and assess hearts donated after circulatory death for transplantation to increase the pool of donor…NCT03831048·La Jolla, California and 24 others

CompletedSafety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas CancerThe GI-4000 therapeutic vaccine or placebo will be injected under the skin of post-resection, non-metastatic pancreas cancer patients.NCT00300950·Birmingham, Alabama and 27 others

CompletedEfficacy, Safety, and Tolerability of COMP360 in Participants With TRDEfficacy, Safety, and Tolerability of a single administration of COMP360 in participants with treatment-resistant depression (TRD)NCT05624268·Tuscon, Arizona and 39 others

CompletedGlargine U300 Hospital TrialThe purpose of this study is to find out if treatment with Glargine U300 when compared to Glargine U100 will result in similar sugar control in patients with Type 2 Diabetes…NCT03013985·Atlanta, Georgia and 3 others

CompletedLong Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus ErythematosusThe purpose of this study is to characterise long-term safety and tolerability of intravenous anifrolumab.NCT02794285·Birmingham, Alabama and 174 others

CompletedStudy to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive AdultsThe purpose of the study was to evaluate the safety and efficacy of the emtricitabine (FTC)/rilpivirine (RPV)/tenofovir disoproxil fumarate (TDF) single-tablet regimen (STR)…NCT01309243·Birmingham, Alabama and 150 others

Active not recruitingPost Approval Study (PAS) of the OPTIMIZER Smart and CCM TherapyThe OPTIMIZER Smart Post-Approval Study is a prospective, multi-center, non-randomized, single arm open label study of 620 subjects receiving an OPTIMIZER implant as standard of…NCT03970343·Mesa, Arizona and 89 others

CompletedA Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell CountsThe purpose of this study is to see how often Pneumocystis carinii pneumonia (PCP) occurs in HIV-positive patients who have stopped taking medications that help prevent PCP.NCT00000908·Birmingham, Alabama and 53 others

CompletedTrial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 InhibitionPatients with chronic kidney disease, who have evidence of systemic inflammation with increased cardiovascular risk, will be enrolled into this trial.NCT03926117·Birmingham, Alabama and 48 others

CompletedPhase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)This is a Phase III, randomized, parallel-arm, placebo controlled, double blind, multicenter study assessing the efficacy and safety of durvalumab versus placebo following SoC…NCT04385368·Birmingham, Alabama and 139 others

CompletedEffect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity ImpairmentIdentifying biomarkers to predict the clinical course and benefits of therapy early in the course of the disease remains one of the most urgent and relevant challenges to improve…NCT02788474·Jasper, Alabama and 85 others

CompletedED Management of Severe Hyperglycemia: A Clinical TrialEmergency Department (ED) patients with severe hyperglycemia will be randomized to two treatment goals: discharge glucose less than 600 mg/dL or less than 350 mg/dL.NCT02478190·Minneapolis, Minnesota

CompletedEvaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected AdultsPeople with HIV are at risk for cardiovascular disease (CVD).NCT02344290·Birmingham, Alabama and 136 others

CompletedNon-invasive Chromosomal Examination of Trisomy StudyThe purpose of this blinded, multi-center, prospective, case-controlled study is to compare the Ariosa Harmony™ Prenatal Test for trisomy 21 detection with a standard…NCT01511458·Tucson, Arizona and 35 others

CompletedA Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic CancerA study to evaluate AGS-1C4D4 administered in combination with Gemcitabine chemotherapy in subjects with Metastatic Pancreatic Cancer.NCT00902291·La Jolla, California and 35 others

CompletedPaclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00002717·Birmingham, Alabama and 51 others

CompletedA Study With SAGE-547 for Super-Refractory Status EpilepticusThis is a randomized, double-blind, placebo-controlled trial, designed to evaluate the efficacy and safety of SAGE-547 administered as a continuous intravenous infusion to…NCT02477618·Birmingham, Alabama and 170 others

PreviousPage 229 of 391Next

Diabetes

in Minneapolis

Heart Diseasein Minneapolis